The following section deals with Pharmaceutical Ingredients used for manufacturing the medicinal products
Active Pharmaceutical Ingredients
Cambrex, the leading manufacturer of small molecule innovator and generic APIs and finished dosage forms, announced it has entered into a definitive agreement to acquire Avista Pharma Solutions.
Mapi Pharma (Israel), a privately held, fully integrated, clinical stage biopharmaceutical company has completed an equity investment of $10 million.
GSK launched a new £54 million ($70.3 million) production building to make APIs for Ellipta, a drug to treat chronic obstructive pulmonary disease.
Dr. Reddy’s Laboratories entered into a definitive agreement for the sale of its API manufacturing business unit to Therapiva Private, an emerging generics pharmaceutical company.
BioDuro, a leading global life sciences contract research and development organization announced that it has established a new drug discovery center for chemistry and biology in San Diego (USA).
Lonza (Switzerland), a specialty CDMO, announced an expansion of its highly potent API (HPAPI) capacity for the specific support of antibody drug conjugate (ADC) payload manufacturing. This latest ...